Ephrin-B3 ligand promotes glioma invasion through activation of Rac1

Mitsutoshi Nakada, Kelsey L. Drake, Satoko Nakada, Jared A. Niska, Michael E. Berens

Research output: Contribution to journalArticle

100 Citations (Scopus)

Abstract

Eph receptor tyrosine kinases are involved in nervous system development. Eph ligands, termed ephrins, are transmembrane proteins that bind to Eph receptors, the mutual activation of which causes repulsive effects in reciprocally contacting cells. Previously, we showed that overexpression of EphB2 in glioma cells increases cell invasion. Here, expression profiles of ephrin-B family members were determined in four glioma cell lines and in invading glioblastoma cells collected by laser capture microdissection. Ephrin-B3 mRNA was upregulated in migrating cells of four of four glioma cell lines (1.3- to 1.7-fold) and in invading tumor cells of eight of eight biopsy specimens (1.2- to 10.0-fold). Forced expression of ephrin-B3 in low expressor cell lines (U87, T98G) stimulated cell migration and invasion in vitro and ex vivo, concomitant with tyrosine phosphorylation of ephrin-B3. In high expressor cell lines (U251, SNB19), ephrin-B3 colocalized with Rac1 to lamellipodia of motile wild-type cells. Cells transfected with ephrin-B3 small interfering RNA (siRNA) showed significant morphologic change and decreased invasion in vitro and ex vivo. Depletion of endogenous ephrin-B3 expression abrogated the increase of migration and invasion induced by EphB2/Fc, indicating increased invasion is dependent on ephrin-B3 activation. Furthermore, using a Rac1-GTP pull-down assay, we showed that ephrin-B3 is associated with Rac1 activation. Reduction of Rac1 by siRNA negated the increased invasion by addition of EphB2/Fc. In human glioma specimens, ephrin-B3 expression and phosphorylation correlated with increasing tumor grade. Immunohistochemistry revealed robust staining for phosphorylated ephrin-B and ephrin-B3 in invading glioblastoma cells. These data show that ephrin-B3 expression and signaling through Rac1 are critically important to glioma invasion.

Original languageEnglish (US)
Pages (from-to)8492-8500
Number of pages9
JournalCancer Research
Volume66
Issue number17
DOIs
StatePublished - Sep 1 2006

Fingerprint

Ephrin-B3
Glioma
Ligands
Ephrins
Eph Family Receptors
Cell Line
Glioblastoma
Small Interfering RNA
Phosphorylation
Laser Capture Microdissection
Pseudopodia
Guanosine Triphosphate

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Nakada, M., Drake, K. L., Nakada, S., Niska, J. A., & Berens, M. E. (2006). Ephrin-B3 ligand promotes glioma invasion through activation of Rac1. Cancer Research, 66(17), 8492-8500. https://doi.org/10.1158/0008-5472.CAN-05-4211

Ephrin-B3 ligand promotes glioma invasion through activation of Rac1. / Nakada, Mitsutoshi; Drake, Kelsey L.; Nakada, Satoko; Niska, Jared A.; Berens, Michael E.

In: Cancer Research, Vol. 66, No. 17, 01.09.2006, p. 8492-8500.

Research output: Contribution to journalArticle

Nakada, M, Drake, KL, Nakada, S, Niska, JA & Berens, ME 2006, 'Ephrin-B3 ligand promotes glioma invasion through activation of Rac1', Cancer Research, vol. 66, no. 17, pp. 8492-8500. https://doi.org/10.1158/0008-5472.CAN-05-4211
Nakada, Mitsutoshi ; Drake, Kelsey L. ; Nakada, Satoko ; Niska, Jared A. ; Berens, Michael E. / Ephrin-B3 ligand promotes glioma invasion through activation of Rac1. In: Cancer Research. 2006 ; Vol. 66, No. 17. pp. 8492-8500.
@article{311dbebbca424d7093ee03baec6fe15d,
title = "Ephrin-B3 ligand promotes glioma invasion through activation of Rac1",
abstract = "Eph receptor tyrosine kinases are involved in nervous system development. Eph ligands, termed ephrins, are transmembrane proteins that bind to Eph receptors, the mutual activation of which causes repulsive effects in reciprocally contacting cells. Previously, we showed that overexpression of EphB2 in glioma cells increases cell invasion. Here, expression profiles of ephrin-B family members were determined in four glioma cell lines and in invading glioblastoma cells collected by laser capture microdissection. Ephrin-B3 mRNA was upregulated in migrating cells of four of four glioma cell lines (1.3- to 1.7-fold) and in invading tumor cells of eight of eight biopsy specimens (1.2- to 10.0-fold). Forced expression of ephrin-B3 in low expressor cell lines (U87, T98G) stimulated cell migration and invasion in vitro and ex vivo, concomitant with tyrosine phosphorylation of ephrin-B3. In high expressor cell lines (U251, SNB19), ephrin-B3 colocalized with Rac1 to lamellipodia of motile wild-type cells. Cells transfected with ephrin-B3 small interfering RNA (siRNA) showed significant morphologic change and decreased invasion in vitro and ex vivo. Depletion of endogenous ephrin-B3 expression abrogated the increase of migration and invasion induced by EphB2/Fc, indicating increased invasion is dependent on ephrin-B3 activation. Furthermore, using a Rac1-GTP pull-down assay, we showed that ephrin-B3 is associated with Rac1 activation. Reduction of Rac1 by siRNA negated the increased invasion by addition of EphB2/Fc. In human glioma specimens, ephrin-B3 expression and phosphorylation correlated with increasing tumor grade. Immunohistochemistry revealed robust staining for phosphorylated ephrin-B and ephrin-B3 in invading glioblastoma cells. These data show that ephrin-B3 expression and signaling through Rac1 are critically important to glioma invasion.",
author = "Mitsutoshi Nakada and Drake, {Kelsey L.} and Satoko Nakada and Niska, {Jared A.} and Berens, {Michael E.}",
year = "2006",
month = "9",
day = "1",
doi = "10.1158/0008-5472.CAN-05-4211",
language = "English (US)",
volume = "66",
pages = "8492--8500",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "17",

}

TY - JOUR

T1 - Ephrin-B3 ligand promotes glioma invasion through activation of Rac1

AU - Nakada, Mitsutoshi

AU - Drake, Kelsey L.

AU - Nakada, Satoko

AU - Niska, Jared A.

AU - Berens, Michael E.

PY - 2006/9/1

Y1 - 2006/9/1

N2 - Eph receptor tyrosine kinases are involved in nervous system development. Eph ligands, termed ephrins, are transmembrane proteins that bind to Eph receptors, the mutual activation of which causes repulsive effects in reciprocally contacting cells. Previously, we showed that overexpression of EphB2 in glioma cells increases cell invasion. Here, expression profiles of ephrin-B family members were determined in four glioma cell lines and in invading glioblastoma cells collected by laser capture microdissection. Ephrin-B3 mRNA was upregulated in migrating cells of four of four glioma cell lines (1.3- to 1.7-fold) and in invading tumor cells of eight of eight biopsy specimens (1.2- to 10.0-fold). Forced expression of ephrin-B3 in low expressor cell lines (U87, T98G) stimulated cell migration and invasion in vitro and ex vivo, concomitant with tyrosine phosphorylation of ephrin-B3. In high expressor cell lines (U251, SNB19), ephrin-B3 colocalized with Rac1 to lamellipodia of motile wild-type cells. Cells transfected with ephrin-B3 small interfering RNA (siRNA) showed significant morphologic change and decreased invasion in vitro and ex vivo. Depletion of endogenous ephrin-B3 expression abrogated the increase of migration and invasion induced by EphB2/Fc, indicating increased invasion is dependent on ephrin-B3 activation. Furthermore, using a Rac1-GTP pull-down assay, we showed that ephrin-B3 is associated with Rac1 activation. Reduction of Rac1 by siRNA negated the increased invasion by addition of EphB2/Fc. In human glioma specimens, ephrin-B3 expression and phosphorylation correlated with increasing tumor grade. Immunohistochemistry revealed robust staining for phosphorylated ephrin-B and ephrin-B3 in invading glioblastoma cells. These data show that ephrin-B3 expression and signaling through Rac1 are critically important to glioma invasion.

AB - Eph receptor tyrosine kinases are involved in nervous system development. Eph ligands, termed ephrins, are transmembrane proteins that bind to Eph receptors, the mutual activation of which causes repulsive effects in reciprocally contacting cells. Previously, we showed that overexpression of EphB2 in glioma cells increases cell invasion. Here, expression profiles of ephrin-B family members were determined in four glioma cell lines and in invading glioblastoma cells collected by laser capture microdissection. Ephrin-B3 mRNA was upregulated in migrating cells of four of four glioma cell lines (1.3- to 1.7-fold) and in invading tumor cells of eight of eight biopsy specimens (1.2- to 10.0-fold). Forced expression of ephrin-B3 in low expressor cell lines (U87, T98G) stimulated cell migration and invasion in vitro and ex vivo, concomitant with tyrosine phosphorylation of ephrin-B3. In high expressor cell lines (U251, SNB19), ephrin-B3 colocalized with Rac1 to lamellipodia of motile wild-type cells. Cells transfected with ephrin-B3 small interfering RNA (siRNA) showed significant morphologic change and decreased invasion in vitro and ex vivo. Depletion of endogenous ephrin-B3 expression abrogated the increase of migration and invasion induced by EphB2/Fc, indicating increased invasion is dependent on ephrin-B3 activation. Furthermore, using a Rac1-GTP pull-down assay, we showed that ephrin-B3 is associated with Rac1 activation. Reduction of Rac1 by siRNA negated the increased invasion by addition of EphB2/Fc. In human glioma specimens, ephrin-B3 expression and phosphorylation correlated with increasing tumor grade. Immunohistochemistry revealed robust staining for phosphorylated ephrin-B and ephrin-B3 in invading glioblastoma cells. These data show that ephrin-B3 expression and signaling through Rac1 are critically important to glioma invasion.

UR - http://www.scopus.com/inward/record.url?scp=33748997415&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748997415&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-05-4211

DO - 10.1158/0008-5472.CAN-05-4211

M3 - Article

C2 - 16951161

AN - SCOPUS:33748997415

VL - 66

SP - 8492

EP - 8500

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 17

ER -